Part IV: Applied Neuroscience | Chapter 1

Neurological Disorders

Computational models of Alzheimer's disease, Parkinson's disease, epilepsy, and stroke

Understanding Brain Disease Through Computation

Neurological disorders affect over a billion people worldwide. Computational models provide mechanistic understanding of disease processes, from molecular-level protein aggregation in Alzheimer's disease to network-level seizure dynamics in epilepsy. These models guide drug development, predict disease progression, and inform therapeutic interventions.

This chapter covers mathematical models of four major neurological disorders: the amyloid cascade in Alzheimer's, dopamine depletion in Parkinson's, excitability transitions in epilepsy, and spreading depolarization in stroke. Each model connects molecular mechanisms to observable symptoms and clinical outcomes.

1. Alzheimer's Disease

Alzheimer's disease (AD) is characterized by progressive memory loss and cognitive decline, driven by amyloid-beta plaques, tau neurofibrillary tangles, and synaptic loss. The amyloid cascade hypothesis proposes that amyloid-beta accumulation initiates a pathological cascade leading to neurodegeneration.

Derivation 1: Amyloid-Beta Aggregation Kinetics

The Smoluchowski coagulation equation models amyloid aggregation. Let $c_k(t)$ be the concentration of aggregates of size $k$:

$$\frac{dc_k}{dt} = \frac{1}{2}\sum_{i+j=k} K_{ij} c_i c_j - c_k \sum_{j=1}^{\infty} K_{kj} c_j + J_k$$

where $K_{ij}$ is the aggregation kernel and $J_k$ accounts for production and clearance. For a simplified two-compartment model (monomers $m$ and plaques $P$):

$$\frac{dm}{dt} = \alpha - \beta m - \gamma m^2, \quad \frac{dP}{dt} = \gamma m^2 - \delta P$$

where $\alpha$ is production rate, $\beta$ is monomer clearance, $\gamma$ is aggregation rate, and $\delta$ is plaque clearance. The steady state plaque burden is $P^* = \gamma (\alpha/\beta)^2 / \delta$. Anti-amyloid therapies target different parameters: secretase inhibitors reduce $\alpha$, immunotherapy increases $\delta$.

2. Parkinson's Disease

Parkinson's disease results from the loss of dopaminergic neurons in the substantia nigra pars compacta, disrupting the balance between the direct and indirect pathways of the basal ganglia. This leads to bradykinesia, rigidity, tremor, and postural instability.

Derivation 2: Basal Ganglia Rate Model of Parkinsonism

The Albin-DeLong model describes basal ganglia dysfunction through altered firing rates. In the normal state, the firing rate of the GPi (output nucleus) is:

$$r_{\text{GPi}} = r_0 - w_D \cdot r_{\text{Str}_D} + w_{\text{STN}} \cdot r_{\text{STN}}$$

where $r_{\text{Str}_D}$ is the direct pathway striatal output and $r_{\text{STN}}$ is the subthalamic nucleus rate. Dopamine depletion (D = 0 vs. normal D = 1) affects both pathways:

$$r_{\text{Str}_D} = f(D \cdot I_{\text{ctx}}), \quad r_{\text{Str}_I} = f((2-D) \cdot I_{\text{ctx}})$$

D1 receptors in the direct pathway are excitatory ($r \propto D$), while D2 receptors in the indirect pathway are inhibitory ($r \propto 2-D$). With dopamine depletion, the direct pathway weakens (less movement facilitation) and the indirect pathway strengthens (more movement suppression), producing the hypokinetic symptoms of PD. The resulting excessive GPi output inhibits thalamocortical circuits.

3. Epilepsy

Epilepsy is characterized by recurrent seizures — episodes of excessive, synchronized neural activity. Computational models describe seizure onset as a bifurcation in neural dynamics, where the brain transitions from a normal (stable) state to a seizure (oscillatory) state.

Derivation 3: Epileptor Model and Seizure Bifurcations

The Epileptor (Jirsa et al., 2014) is a minimal model capturing seizure onset, evolution, and termination. The fast variables describe seizure dynamics:

$$\dot{x}_1 = y_1 - f_1(x_1, x_2) - z + I_1$$

$$\dot{y}_1 = 1 - 5x_1^2 - y_1$$

The slow variable $z$ (representing metabolic processes) controls transitions:

$$\dot{z} = \frac{1}{\tau_0}\left(4(x_1 - x_0) - z\right)$$

Seizure onset occurs via a saddle-node bifurcation when $z$ decreases below a critical value, and termination occurs via a homoclinic bifurcation when $z$increases. The parameter $x_0$ controls the seizure threshold: more negative values make seizures less likely. This model predicts stereotyped seizure dynamics and has been used to create patient-specific virtual brain models for surgical planning.

Derivation 4: Spreading Depolarization in Stroke

Ischemic stroke triggers spreading depolarization (SD) waves — slow ($\sim$3 mm/min) waves of neuronal depolarization that expand the infarct. The reaction-diffusion model:

$$\frac{\partial [K^+]_o}{\partial t} = D_K \nabla^2 [K^+]_o + f([K^+]_o) - g([K^+]_o)$$

where $[K^+]_o$ is extracellular potassium, $D_K \approx 3 \times 10^{-6}$ cm$^2$/s is the diffusion coefficient, $f$ is the release function (positive feedback), and$g$ is the pump/uptake function. The wave speed is approximately:

$$v \approx 2\sqrt{D_K \cdot f'(K_0^+)} \approx 3 \text{ mm/min}$$

Each SD wave in ischemic tissue causes further energy depletion, expanding the penumbra into infarct. The number of SD waves correlates with final infarct size. Therapeutic targets include NMDA receptor blockers (reducing $f$) and Na$^+$/K$^+$-ATPase enhancers (increasing $g$).

Derivation 5: Network Degeneration Spreading Model

Neurodegenerative diseases spread along neural connections. The network spreading model (Raj et al., 2012) describes atrophy propagation on the connectome:

$$\frac{d\mathbf{x}}{dt} = -\beta \mathbf{L} \mathbf{x}$$

where $\mathbf{x}$ is the vector of regional atrophy, $\mathbf{L}$ is the graph Laplacian of the structural connectome, and $\beta$ is the spreading rate. The solution:

$$\mathbf{x}(t) = e^{-\beta \mathbf{L} t} \mathbf{x}_0 = \sum_k e^{-\beta \lambda_k t} (\mathbf{u}_k^T \mathbf{x}_0) \mathbf{u}_k$$

Starting from a seed region $\mathbf{x}_0$, atrophy spreads preferentially along highly connected pathways. The eigenmodes of $\mathbf{L}$ predict spatial patterns of degeneration: low eigenvalue modes (affecting connected regions) dominate at early stages, while high eigenvalue modes emerge later. This model successfully predicts the progression patterns of Alzheimer's (from entorhinal cortex) and Parkinson's (from substantia nigra).

4. Historical Development

  • 1817: James Parkinson publishes "An Essay on the Shaking Palsy," first describing the disease.
  • 1906: Alois Alzheimer describes plaques and tangles in a patient with progressive dementia.
  • 1929: Hans Berger records epileptic EEG abnormalities, enabling noninvasive seizure diagnosis.
  • 1960: Hornykiewicz discovers dopamine depletion in PD, leading to L-DOPA therapy.
  • 1992: Hardy and Higgins formulate the amyloid cascade hypothesis for AD.
  • 2006: Braak staging demonstrates that tau pathology spreads in a stereotyped pattern along connected regions.
  • 2014: Jirsa et al. develop the Epileptor model for patient-specific seizure prediction.
  • 2020s: Anti-amyloid antibodies (lecanemab, donanemab) show disease modification in AD clinical trials.

5. Applications

Drug Development

Kinetic models of amyloid aggregation predict optimal dosing for anti-amyloid therapies. Basal ganglia models guide development of dopamine replacement strategies. Virtual patient models enable in-silico clinical trials.

Epilepsy Surgery

Patient-specific Epileptor models on individual connectomes predict seizure propagation zones and optimal resection targets. Virtual brain surgery simulations improve outcomes for drug-resistant epilepsy.

Stroke Treatment

Spreading depolarization models predict penumbra evolution, guiding the therapeutic time window for thrombolysis and thrombectomy. Neuroprotective strategies target SD wave propagation.

Early Detection

Network spreading models predict which brain regions will atrophy next, enabling early diagnosis from a single scan. Computational biomarkers detect presymptomatic disease years before clinical onset.

6. Computational Exploration

Neurological Disorders: Alzheimer, Parkinson, Epilepsy, and Stroke Models

Python
script.py313 lines

Click Run to execute the Python code

Code will be executed with Python 3 on the server

Chapter Summary

  • Alzheimer's: amyloid aggregation follows $dP/dt = \gamma m^2 - \delta P$; therapies target production, aggregation, or clearance.
  • Parkinson's: dopamine depletion shifts the direct/indirect pathway balance, increasing GPi output and suppressing movement.
  • Epilepsy: seizures arise from saddle-node bifurcations in the Epileptor; the slow variable $z$ controls transitions.
  • Stroke: spreading depolarization waves expand infarct at ~3 mm/min via reaction-diffusion dynamics.
  • Network spreading: neurodegeneration propagates along connectome edges, predicted by graph Laplacian eigenmodes.